Two Philadelphia CyberKnife student authors present at Pennsylvania Society of Oncology and Hematology meeting

Two student authors from Philadelphia CyberKnife presented at the Philadelphia Society of Oncology and Hematology’s annual scientific meeting from October 2 – 3 in Lafayette Hill, Pennsylvania. 

The Pennsylvania Society of Oncology and Hematology (PSOH) is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.  Membership in the organization includes oncologists, hematologists, surgeons, radiation oncologists, oncology nurses, tumor registrars, pharmacists and other clinical professionals who care for cancer patients. 

There are two types of presentations accepted by the society: oral and poster.  In order to present, authors first had to submit a written abstract about their topic of choice.  The abstracts were then evaluated by a PSOH review panel and the top five were selected to be presented at the annual meeting. 

Shaharyar Ahmad and Anthony Ricco were the authors whose presentations were accepted by the society. 

Shaharyar, a second year medical student at Drexel University College of Medicine in Philadelphia, PA, presented an oral presentation titled Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastases: Is There a Difference in Outcome between First and Second Brain Metastatic Event? 

Ricco, a fourth year medical student at Thomas Jefferson University in Philadelphia, PA, presented on Adult Onset Ewing Sarcoma Presenting with Orbital-Displacing Frontal Oligo-metastasis: A Case Report.  He also did a second presentation on Predictors of Long-Term Survival for Localized Prostate Cancer Treated with High Dose IMRT Stratified by NCCN 2015 Guidelines in a Community Hospital Setting, which he won first place in the poster competition for. 

Philadelphia CyberKnife would like to thank and congratulate Shaharyar and Anthony on a job well done! 

Photo caption:  Shaharyar Ahmad and Anthony Ricco, presenters at the annual PSOH meeting, pose with Dr. Rachelle M. Lanciano, Radiation Oncologist at Philadelphia CyberKnife.